Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Central Pharmaceuticals, Inc. (often abbreviated as Cent Pharms in regulatory filings) was a pharmaceutical company based in Seymour, Indiana, specializing in the manufacture of generic prescription and over-the-counter drugs. Founded in 1904 as The Central Pharmacal Co., the company developed a diverse portfolio of products including corticosteroids, analgesics, and respiratory treatments. In 1995, the company was acquired by the German pharmaceutical firm Schwarz Pharma for approximately 177.5 million USD. Following subsequent acquisitions, the Seymour facility became part of UCB and later Kremers Urban Pharmaceuticals, which is now part of Lannett.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cent Pharms.